It is a two-arm prospective interventional study. 40 babies in both groups will be enrolment in the study. In the intervention group, babies will take 1 ml/kg/day of the study product (ULTRA PREMIUM) after full enteral feeding. Supplementation will continue until discharge or the 36th week. Blood samples will be taken for serum Total antioxidant capacity and Malondialdehyde levels before the intervention and on the 14th day of the control group. At the end of the study, serum will be taken again for control values. Daily lipid intake amounts will be recorded through breast milk analysis. Lipid profile will be monitored weekly The growth parameters of babies will be monitored daily It will be evaluated at the end of the study in terms of ROP, BPD, and NEC. At the end of the study, the data of babies in both groups will be compared.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
80
Babies who have fully enteral feeding will take oral, 1 ml/kg/day of extra virgin olive-oil
Bursa City Hospital
Bursa, Turkey (Türkiye)
RECRUITINGNumber of patients who completed the study
To enrolment of 40 babies in the study in both groups
Time frame: 15 months
Postnatal growth retardation rates
Daily weight intake amounts of babies in both groups
Time frame: 18 months
Frequency and severity of retinopathy of prematurity
Frequency and severity of retinopathy of prematurity
Time frame: 18 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.